Armenia vs Niger: Access to anti-retroviral drugs, male
Armenia
52.0%
in 2024
Niger
56.0%
in 2024
Armenia rank
113th
Niger rank
110th
Access to anti-retroviral drugs, male over time
- Armenia
- Niger
How they compare
Niger currently reports 56.0% against 52.0% in Armenia, a difference of 4.0%.
That makes Niger's figure about 1.1 times Armenia's.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Niger ahead.
Armenia ranks 113th and Niger ranks 110th of 141 countries.
Across the 3 decades both report, Armenia averaged higher in 1 and Niger in 2.
Head to head by decade
| Decade | Armenia | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.4% | 3.4% | 1.0% | Armenia |
| 2010s | 26.3% | 32.7% | 6.4% | Niger |
| 2020s | 46.2% | 56.0% | 9.8% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Armenia or Niger?
- Niger, at 56.0% against 52.0% in Armenia as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Armenia and Niger?
- 4.0%, with Niger ahead.
- How many years of comparable data are there for Armenia and Niger?
- 25 years are reported by both, from 2000 to 2024.
- How do Armenia and Niger rank globally for access to anti-retroviral drugs, male?
- Armenia ranks 113th and Niger ranks 110th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.